中文名:N/A
英文名:FAP inhibitors
CAS:N/A
一、Product parameters:
1.Molecular formula:C18H16F2N4O3
2.Molecular weight:374.3
3.Packaging specification:1g、5g、10g, flexible packaging, including 100mg packaging and 500mg 1g and 5g large packaging
Product structure:
二、Reaction characteristics:
成纤维细胞活化蛋白FAP inhibitors,其中FAP(也称为seprase),是一种II型跨膜丝氨酸蛋白酶。FAP属于MMP家族的一员。质膜和可溶性形式都表现出脯氨酸切割后的内肽酶活性,对Ala/Ser-Gly-Pro-Ser/Asn/Ala共有序列具有显著的偏好。还可降解明胶,使I型胶原热变性。还具有二肽基肽酶活性,优选Ala-Pro、Ile-Pro、Gly-Pro、Arg-Pro和Pro-Pro。
FAP inhibitors主要作用是抑制细胞增殖和迁移,研究表明,FAP inhibitor还可以用于控制肥胖。 此外,FAP inhibitor还可以通过抑制脂肪细胞增殖和分化来控制肥胖和代谢疾病的发生。FAP inhibitor的药理作用机制是通过抑制II型跨膜丝氨酸蛋白酶的活性来实现的。它主要水解肽键上的羧基端,对于体内多种细胞因子的活性具有重要的调节作用。FAP inhibitors的作用机制主要是通过与FAP的活性位点结合,抑制其水解活性。
(上述信息均由陕西新研博美生物科技有限公司的小编木木所整理)
三、Matters for use:
It is sensitive to light and temperature. In order to use the reagent effectively, the material should always be kept in a low temperature dry condition, away from light, and avoid frequent thawing and freezing.
四、storage conditions:
Store at - 20 ℃ as much as possible. If conditions permit, the material can be treated under inert gas to obtain better stability of the reagent.
【Reagent related products】
DOTAGA-DTyr(3I)-DPhe-DLys(Sub-Lys-urea-Glu),PSMA IandT
cyclo(RGDFK(DOTA))
DOTA-E[c(RGDfK)2]
DOTA-cyclo(RGDyK)
DOTA-E-[cyclo(RGDfK(Acp))]2
FAP-2286
PSMA I&F
DUPA(OtBu)-OH
Vipivotide tetraxetan Linker
NOTA-octreotide
DOTA-cyclo(RGDfK) acetate
PSMA-BCH
PSMA I&T
DOTA-NOC acetate FC-2154
FAPI-4-NH2
Cy5-PEG-Folic Acid,Cyanine5-PEG-FA,MW:3400
Cy5-PEG-Folic Acid,Cyanine5-PEG-FA,MW:2000
Cy5-PEG-Folic Acid,Cyanine5-PEG-FA,MW:1000
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:1000
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:2000
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:3400
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:5000